PARKINSONISM IN MONKEYS PRODUCED BY CHRONIC ADMINISTRATION OF AN ENDOGENOUS SUBSTANCE OF THE BRAIN, TETRAHYDROISOQUINOLINE - THE BEHAVIORAL AND BIOCHEMICAL-CHANGES

被引:79
作者
YOSHIDA, M
NIWA, T
NAGATSU, T
机构
[1] NAGOYA UNIV,SCH MED,DEPT BIOCHEM,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
[2] JICHI MED SCH,DEPT NEUROL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
[3] NAGOYA UNIV BRANCH HOSP,DEPT INTERNAL MED,NAGOYA,JAPAN
关键词
Biopterin; Dopamine; Parkinsonism; Squirrel monkeys; Striatum; Substantia nigra; Tetrahydroisoquinoline; Tyrosine hydroxylase;
D O I
10.1016/0304-3940(90)90768-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have examined the effect of chronic administration of a probable endogenous dopaminergic neurotoxin, tetrahydroisoquinoline (TIQ, 20 mg/kg per day, s.c. for up to 104 days), on squirrel monkeys. Chronically administered TIQ produced motor symptoms similar to parkinsonism in squirrel monkeys even after 7 days' discontinuation of TIQ and the symptomes were alleviated remarkably by levodopa treatment. Biochemical analysis of the brains of TIQ-treated monkeys revealed significant decrease in dopamine (DA) and total biopterin (BP) concentrations, and tyrosine hydroxylase (TH) activity in the substantia nigra, and these biochemical changes were not reversed by 7 days following the termination of chronic administration of TIQ. TIQ was identified in the brain (caudate-putamen) of saline-injected control monkeys by gas chromatography-mass spectrometry. The endogenous levels of TIQ in the caudate-putamen was about 0.15 μg/g, and increased up to 3-4 μg/g, 1 day as well as 7 days following termination of TIQ administration. © 1990.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 22 条
[1]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[2]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[3]   ANALYSIS OF REDUCED FORMS OF BIOPTERIN IN BIOLOGICAL TISSUES AND FLUIDS [J].
FUKUSHIMA, T ;
NIXON, JC .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (01) :176-188
[4]   DOPAMINERGIC NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE IN MICE [J].
HEIKKILA, RE ;
HESS, A ;
DUVOISIN, RC .
SCIENCE, 1984, 224 (4656) :1451-1453
[5]   TETRAHYDROISOQUINOLINE AND 1-METHYL-TETRAHYDROISOQUINOLINE AS NOVEL ENDOGENOUS AMINES IN RAT-BRAIN [J].
KOHNO, M ;
OHTA, S ;
HIROBE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (01) :448-454
[6]   CHRONIC PARKINSONISM IN HUMANS DUE TO A PRODUCT OF MEPERIDINE-ANALOG SYNTHESIS [J].
LANGSTON, JW ;
BALLARD, P ;
TETRUD, JW ;
IRWIN, I .
SCIENCE, 1983, 219 (4587) :979-980
[7]   PRESENCE OF TETRAHYDROISOQUINOLINE AND 1-METHYL-TETRAHYDRO-ISOQUINOLINE IN FOODS - COMPOUNDS RELATED TO PARKINSONS-DISEASE [J].
MAKINO, Y ;
OHTA, S ;
TACHIKAWA, O ;
HIROBE, M .
LIFE SCIENCES, 1988, 43 (04) :373-378
[8]   INHIBITION OF MITOCHONDRIAL RESPIRATION BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MOUSE-BRAIN INVIVO [J].
MIZUNO, Y ;
SUZUKI, K ;
SONE, N ;
SAITOH, T .
NEUROSCIENCE LETTERS, 1988, 91 (03) :349-353
[9]   INHIBITION OF MITOCHONDRIAL NADH-UBIQUINONE OXIDOREDUCTASE ACTIVITY BY 1-METHYL-4-PHENYLPYRIDINIUM ION [J].
MIZUNO, Y ;
SAITOH, T ;
SONE, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 143 (01) :294-299
[10]   HIGHLY SENSITIVE ASSAY FOR TYROSINE-HYDROXYLASE ACTIVITY BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
NAGATSU, T ;
OKA, K ;
KATO, T .
JOURNAL OF CHROMATOGRAPHY, 1979, 163 (03) :247-252